TrialClinical genitourinary cancer2021

A Phase 2 Trial of Abiraterone Followed by Randomization to Addition of Dasatinib or Sunitinib in Men With Metastatic Castration-Resistant Prostate Cancer.

Nicholas Spetsieris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.